Michael S Perry - Net Worth and Insider Trading
Michael S Perry Net Worth
The estimated net worth of Michael S Perry is at least $4 Million dollars as of 2024-04-20. Michael S Perry is the Director of AVITA Medical Inc and owns about 229,543 shares of AVITA Medical Inc (RCEL) stock worth over $2 Million. Michael S Perry is the Director of Arrowhead Pharmaceuticals Inc and owns about 85,500 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $2 Million. Michael S Perry is also the Director of Armata Pharmaceuticals Inc and owns about 29,381 shares of Armata Pharmaceuticals Inc (ARMP) stock worth over $78,300. Details can be seen in Michael S Perry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael S Perry has not made any transactions after 2022-11-21 and currently still holds the listed stock(s).
Transaction Summary of Michael S Perry
Michael S Perry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael S Perry owns 5 companies in total, including AVITA Medical Inc (RCEL) , Arrowhead Pharmaceuticals Inc (ARWR) , and Armata Pharmaceuticals Inc (ARMP) among others .
Click here to see the complete history of Michael S Perry’s form 4 insider trades.
Insider Ownership Summary of Michael S Perry
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RCEL | AVITA Medical Inc | 2022-11-21 | director & Chief Executive Officer |
ARWR | Arrowhead Pharmaceuticals Inc | 2022-01-03 | director |
ARMP | Armata Pharmaceuticals Inc | 2019-12-31 | director |
PARD | Poniard Pharmaceuticals Inc | 2012-03-27 | President & CMO |
XENO | Xeno Transplants Corp | 2007-05-03 | director |
Michael S Perry Latest Holdings Summary
Michael S Perry currently owns a total of 3 stocks. Among these stocks, Michael S Perry owns 229,543 shares of AVITA Medical Inc (RCEL) as of November 21, 2022, with a value of $2 Million and a weighting of 49.95%. Michael S Perry owns 85,500 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 3, 2022, with a value of $2 Million and a weighting of 48.08%. Michael S Perry also owns 29,381 shares of Armata Pharmaceuticals Inc (ARMP) as of March 22, 2018, with a value of $78,300 and a weighting of 1.97%.
Latest Holdings of Michael S Perry
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RCEL | AVITA Medical Inc | 2022-11-21 | 229,543 | 8.64 | 1,983,252 |
ARWR | Arrowhead Pharmaceuticals Inc | 2022-01-03 | 85,500 | 22.33 | 1,909,215 |
ARMP | Armata Pharmaceuticals Inc | 2018-03-22 | 29,381 | 2.67 | 78,300 |
Holding Weightings of Michael S Perry
Michael S Perry Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael S Perry has made a total of 5 transactions in AVITA Medical Inc (RCEL) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in AVITA Medical Inc is the sale of 150,000 shares on November 21, 2022, which brought Michael S Perry around $1 Million.
According to the SEC Form 4 filings, Michael S Perry has made a total of 4 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 4,500 shares on January 3, 2022, which brought Michael S Perry around $291,195.
According to the SEC Form 4 filings, Michael S Perry has made a total of 0 transactions in Armata Pharmaceuticals Inc (ARMP) over the past 5 years. The most-recent trade in Armata Pharmaceuticals Inc is the acquisition of 20,900 shares on March 22, 2018, which cost Michael S Perry around $198,963.
Insider Trading History of Michael S Perry
- 1
Michael S Perry Trading Performance
GuruFocus tracks the stock performance after each of Michael S Perry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael S Perry is 5.17%. GuruFocus also compares Michael S Perry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael S Perry within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael S Perry's insider trading performs compared to the benchmark.
Performance of Michael S Perry
Average Return
Outperforming Transactions
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -0.86 | 5.17 | -20.87 | -71.55 | -58.9 | -31.04 |
Relative Return to S&P 500(%) | -1.86 | 0.96 | -31.69 | -77.49 | -52.26 | -45.26 |
Michael S Perry Ownership Network
Ownership Network List of Michael S Perry
Ownership Network Relation of Michael S Perry
Michael S Perry Owned Company Details
What does AVITA Medical Inc do?
Who are the key executives at AVITA Medical Inc?
Michael S Perry is the director & Chief Executive Officer of AVITA Medical Inc. Other key executives at AVITA Medical Inc include CFO David D O'toole , General Counsel Donna Shiroma , and Chief Financial Officer Michael Holder .
AVITA Medical Inc (RCEL) Insider Trades Summary
Over the past 18 months, Michael S Perry made 1 insider transaction in AVITA Medical Inc (RCEL) with a net sale of 150,000. Other recent insider transactions involving AVITA Medical Inc (RCEL) include a net purchase of 16,700 shares made by David D O'toole , a net sale of 5,018 shares made by Jeremy Curnock Cook , and a net sale of 4,193 shares made by Donna Shiroma .
In summary, during the past 3 months, insiders sold 0 shares of AVITA Medical Inc (RCEL) in total and bought 1,250 shares, with a net purchase of 1,250 shares. During the past 18 months, 160,656 shares of AVITA Medical Inc (RCEL) were sold and 16,700 shares were bought by its insiders, resulting in a net sale of 143,956 shares.
AVITA Medical Inc (RCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
AVITA Medical Inc Insider Transactions
Michael S Perry Mailing Address
Above is the net worth, insider trading, and ownership report for Michael S Perry. You might contact Michael S Perry via mailing address: C/o Biotransplant Inc, 196 Boston Ave Suite 2800, Medford Ma 02155.